|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from Operating Activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation and amortization | |||||
| Bad debt (recovery) expense | |||||
| Non-cash lease expense from right-of-use assets | |||||
| Stock-based compensation | |||||
| Forfeiture of unvested stock options | |||||
| Loss on disposal of assets | |||||
| Casualty loss on inventory | |||||
| Impairment charges - property and equipment | |||||
| Impairment charges - intangible assets | |||||
| Impairment charges - right-of use assets | |||||
| Impairment charges - goodwill | |||||
| Non-cash revenue from digital assets | |||||
| Non-cash expenses from digital assets | |||||
| Unrealized loss on digital assets | |||||
| Changes in assets and liabilities: | |||||
| Accounts receivable | |||||
| Prepaid expenses and other current assets | |||||
| Inventory | |||||
| Other assets | |||||
| Accounts payable | |||||
| Accrued expenses and other current liabilities | |||||
| Deferred revenue | |||||
| Lease liabilities | |||||
| Net cash used in operating activities | |||||
| Cash flows from Investing Activities: | |||||
| Proceeds on sale of equipment | |||||
| Purchases of property and equipment | |||||
| Purchases of digital assets | |||||
| Net cash used in investing activities | |||||
| Cash flows from Financing Activities: | |||||
| Proceeds from preferred stock warrant exercises, net of issuance costs | |||||
| Preferred Warrants | |||||
| Common Stock Warrants | |||||
| Proceeds from private placement, net of issuance costs | |||||
| Net proceeds from exercise of common stock warrants | |||||
| Preferred Warrants | |||||
| Total net proceeds from exercise of common stock warrants | |||||
| Proceeds from exercise of common stock warrants, net of costs | |||||
| Common Stock Warrants | |||||
| Preferred Warrants | |||||
| Net cash provided by financing activities | |||||
| Net decrease in cash and cash equivalents | |||||
| Cash and restricted cash at beginning of year | |||||
| Cash and cash equivalents at end of year | |||||
| Supplemental disclosures of cash flow information: | |||||
| Cash paid during the period for interest | |||||
| Cash paid for income taxes | |||||
| Reconciliation of cash and cash equivalents | |||||
| Cash | |||||
| Current certificates of deposit | |||||
| Total cash and cash equivalents | |||||
| Non-cash investing and financing activities: | |||||
| New operating lease agreement | |||||
| Common warrant issuance | |||||
| Series F Preferred Stock conversion | |||||
| Dividends, Preferred Stock | |||||
| Warrant modification | |||||
| Induced exercise of common stock warrants | |||||
| Common stock issued for conversion of Preferred Stock and accrued dividends | |||||
Loading...